Overexpression of CD200 was observed in cutaneous squamous cell carcinoma and myelodysplastic syndrome, suggesting that CD200 could also be used as a prognostic tumor marker [146, 147]. This evidence concerns the gene CD200 and cutaneous squamous cell carcinoma.